In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
Ask the Expert
Angela Katrichis speaks with a patient
The Best Ways to Cope with Active Surveillance

Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.
Feature
Three men standing in an airport
Exporting Expertise: How MSK Is Helping to Improve Cancer Care and Research in Ghana

Learn about a new initiative led by MSK pediatric hematologic oncologist Tanya Trippett that aims to improve cancer care and research in Ghana.
Feature
Memorial Sloan Kettering breast cancer expert Mark Robson.
Who Should Be Tested for a BRCA Mutation? The Science Is Evolving

Though questions remain about how best to use genetic testing for cancer, the trend is toward more inclusive criteria.
In the Lab
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Virtual community events in April
MSK Honors Minority Cancer Awareness Month with Virtual Community Events

Free, virtual programs in English and Spanish for our community.
In the Clinic
Chemical biologist Gabriela Chiosis in a laboratory
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
In the Lab
Dmitriy Zamarin and Sohrab Shah
MSK Team Focuses on Resistance to Immunotherapy in Ovarian Cancer

A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024

New MSK research helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People

Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.